- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
ICMR defends timeline for coronavirus vaccine trials
Mumbai: India's leading clinical research agency said Saturday its decision to fast-track development of a potential coronavirus vaccine was in line with international standards after health experts raised concerns about the schedule for clinical trials.
The Indian Council of Medical Research issued a statement after a letter was leaked on Friday showing ICMR Director General Balram Bhargava as saying the agency "envisaged" launch of the vaccine for public health use by Aug. 15, with the aim to begin patient enrolment for human trials by July 7.
The vaccine, being jointly developed by India's Bharat Biotech and ICMR, is one of several candidates being tested globally to fight the coronavirus pandemic.
Vaccine trials usually take years to complete, though regulators have allowed testing on some potential vaccines to be fast-tracked in light of the public health emergency.
The ICMR's timeline drew criticism here from health experts in India, who expressed concern the trials would compromise patient safety and ethics.
"Everything will be dependent on the clinical trial results," ICMR spokesman Lokesh Sharma told Reuters.
The ICMR's statement said the leaked letter "was meant to cut unnecessary red tape, without bypassing any necessary process, and speed up recruitment of participants."
The statement said the aim was "to complete these phases at the earliest so that population-based trials for efficacy could be initiated without delay."
It added: "In the larger public health interest, it is important for ICMR to expedite the clinical trials with a promising indigenous vaccine.
"ICMR's process is exactly in accordance with the globally accepted norms to fast-track the vaccine development for diseases of pandemic potential wherein human and animal trials can continue in parallel."
Read also: FIRST: Bharat Biotech Covid-19 Vaccine COVAXIN Gets DCGI Nod For Human Trials
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751